No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
RAPT RAPT Therapeutics
- 7.800
- -0.100-1.27%
Close Apr 25 16:00 ET
- 7.860
- +0.060+0.77%
Post 17:43 ET
271.44MMarket Cap-2557P/E (TTM)
7.915High7.520Low855.15KVolume7.820Open7.900Pre Close6.65MTurnover3.11%Turnover RatioLossP/E (Static)34.80MShares27.35052wk High1.85P/B214.55MFloat Cap6.86052wk Low--Dividend TTM27.51MShs Float51.210Historical High--Div YieldTTM5.00%Amplitude6.860Historical Low7.774Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Daily rights tracking | Market capitalization soared to $55.6 billion overnight! Tesla's bullish sentiment is picking up
Nvidia fell more than 3% overnight, and some large investors bought two large bearish orders in a row when the stock price was 794.2 US dollars, involving nearly 50 million US dollars.
Top 10 Stocks With Upwards and Downwards Daily Percentage Change - Piper Sandler
Hold Rating on RAPT Therapeutics Amid Promising Data and Regulatory Uncertainties
Maintaining Hold Rating on RAPT Therapeutics Amidst Mixed Clinical Results and Regulatory Uncertainty
HC Wainwright & Co. : Reiterates RAPT Therapeutics (RAPT.US) neutral rating.
HC Wainwright & Co. : Reiterates RAPT Therapeutics (RAPT.US) neutral rating.
HC Wainwright & Co. Reiterates Neutral on RAPT Therapeutics
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates RAPT Therapeutics (NASDAQ:RAPT) with a Neutral.
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg